FDA
label_change
· 2022-10-07
FDA Approved: TIVICAY PD — Supplemental Application (ViiV Healthcare Company)
Summary
The FDA approved a supplemental application for Tivicay PD (dolutegravir sodium) submitted by ViiV Healthcare Company.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for TIVICAY PD (DOLUTEGRAVIR SODIUM)